Qvar 100 inhaler

Country: যুক্তরাজ্য

ভাষা: ইংরেজি

সূত্র: MHRA (Medicines & Healthcare Products Regulatory Agency)

সক্রিয় উপাদান:

Beclometasone dipropionate

থেকে পাওয়া:

CST Pharma Ltd

এটিসি কোড:

R03BA01

INN (International Name):

Beclometasone dipropionate

ডোজ:

100microgram/1dose

ফার্মাসিউটিকাল ফর্ম:

Pressurised inhalation

প্রশাসন রুট:

Inhalation

শ্রেণী:

No Controlled Drug Status

প্রেসক্রিপশন টাইপ:

Caution - AMP level prescribing advised

পণ্য সারাংশ:

BNF: 03020000; GTIN: 5055946803685

তথ্য লিফলেট

PATIENT INFORMATION LEAFLET
QVAR
®
100 INHALER
(beclometasone dipropionate)
Your medicine will be referred to as Qvar Inhaler throughout this
leaflet.
Qvar is also available in another strength.
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or pharmacist.
•
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs of illness are the same
as
yours.
•
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible side effects not listed in this leaflet.
See
section 4.
WHAT IS IN THIS LEAFLET
1. WHAT QVAR INHALER IS AND WHAT IT IS USED FOR
2. WHAT YOU NEED TO KNOW BEFORE YOU USE QVAR INHALER
3. HOW TO USE QVAR INHALER
4. POSSIBLE SIDE EFFECTS
5. HOW TO STORE QVAR INHALER
6. CONTENTS OF PACK AND OTHER INFORMATION
1. WHAT QVAR INHALER IS AND WHAT IT IS USED FOR
Qvar Inhaler contains beclometasone dipropionate, which is one of a
group of medicines known as corticosteroids.
Qvar Inhaler is used to prevent the symptoms of mild, moderate, or
severe asthma, in patients who require regular treatment.
HOW YOUR MEDICINE WORKS
•
Qvar Inhaler works deep in your lungs to make breathing easier by
reducing the inflammation, swelling and irritation in the airways.
This
type of medicine is known as a ‘preventer’. It needs to be taken
regularly every day, even if you have no symptoms.
•
This inhaler will not give immediate relief of wheezing or
breathlessness during a sudden asthma attack. You will need to use a
‘reliever’ inhaler, which contains a different medicine. You
should still
continue to use this inhaler.
2. WHAT YOU NEED TO KNOW BEFORE YOU USE QVAR INHALER
DO NOT USE QVAR INHALER IF YOU:
•
are allergic to beclometasone dipropionate or any of the other
ingredients of this medicine (listed in section 6)
•
are allergic to other simil

পণ্য বৈশিষ্ট্য

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Qvar Easi-Breathe 100 micrograms per actuation inhaler
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Beclometasone Dipropionate 100 micrograms per metered (ex-valve) dose.
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Pressurised inhalation, solution
A
colourless
solution
in
a
pressurised
aluminium
canister
fitted
with
a
metering valve and an actuator.
Qvar
Easi-Breathe
contains
a
propellant,
which
does
not
contain
any
chlorofluorocarbons (CFCs).
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Prophylactic management of mild, moderate or severe asthma.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Qvar Easi-Breathe is for inhalation use only.
Patients should be instructed in the proper use of their inhaler,
including rinsing out
their mouth with water after use..
NOTE: THE RECOMMENDED TOTAL DAILY DOSE OF QVAR EASI-BREATHE IS LOWER
THAN
THAT FOR CURRENT BECLOMETASONE DIPROPIONATE CONTAINING PRODUCTS AND
SHOULD BE
ADJUSTED TO THE NEEDS OF THE INDIVIDUAL PATIENT.
ADULT STARTING AND MAINTENANCE DOSE:
It is important to gain control of asthma symptoms and optimise
pulmonary function
as soon as possible. When patients’ symptoms remain under
satisfactory control, the
dose should be titrated to the lowest dose at which effective control
of asthma is
maintained.
To be effective inhaled Qvar Easi-Breathe must be used on a regular
basis even when
patients are asymptomatic.
THERAPY IN NEW PATIENTS SHOULD BE INITIATED AT THE FOLLOWING
Mild asthma:
100 to 200 micrograms per day in two divided doses.
Moderate asthma:
200 to 400 micrograms per day in two divided doses.
Severe asthma:
400 to 800 micrograms per day in two divided doses.
Patients on budesonide inhalers may be transferred to Qvar as
described below
The general approach to switching patients to Qvar involves two steps
as detailed
below. Specific guidance on switching well-controlled and
poorly-controlled
(symptomatic) patients is given below the table.
Step 1: Consider